FDA set to review testosterone-boosting drug usage
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
Health Care
Articles
Recent wins worth $4B to Lilly market value
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
Lilly execs make pitch for local preschool education
Eli Lilly and Co. executives on Friday repeated their plea to local businesses to support early childhood education, highlighting the work force development and crime-reduction benefits associated with the effort.
Lilly cancer drug fares well in late-stage study
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
Community Health buys Hilton North for redevelopment
The hospital network will close the 221-room hotel along the Interstate 69 corridor by the end of the year and will begin exploring redevelopment opportunities to meet the growth of the network.
Lilly receives European marketing OK for new insulin
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
Feds OKs $1.8 million for health exchange helpers
The U.S. Department of Health and Human Services is sending Indiana money to help the state's health care plan navigators sign up more residents through a federally run exchange.
Obamacare tax rule that split appeals courts gets rehearing
The full U.S. Court of Appeals will rehear a case on Obamacare tax subsidies, granting a government request in a move that may reduce chances of a new Supreme Court showdown over a central part of the law.
Lilly says new insulin fares better than rival’s in late-stage tests
The Indianapolis-based drugmaker said Thursday that peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
St. Vincent considers $14M sports performance facility at Marian
Marian University, St. Vincent Health and four amateur sports groups have entered into formal discussions that could result in major developments at the northwest-side campus, the university announced Tuesday.
Feds: AIT’s Evans ‘unjustly enriched’ himself in sale to employees
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
Indiana cases could define conflict of interest
The question of what constitutes a conflict of interest and why it matters for public officials has run throughout a string of high-profile ethics scandals in Indiana recently.
Lilly, partner lose appeal to overturn $9 billion Actos court award
Takeda Pharmaceutical Co. and Eli Lilly and Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
Blood Center retrenches after losing major clients to Red Cross
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.
Franciscan cuts its way to higher profits
Franciscan Alliance, which operates three hospitals in the Indianapolis area, is seeing fewer patients this year but is making more money due to expense cuts.
Health commissioner resigns for personal reasons
Dr. William VanNess said Friday he plans to stay on the job until Gov. Pence finds a replacement, saying he likely will stay on until early October.
Mainstreet torques up expansion ambitions
Mainstreet Property Group, already the fastest-growing company in the Indianapolis area, now has the fuel it needs to nearly triple its pace of construction of senior care facilities around the country.
EMS service to lay off 361 workers in Indiana
Rural/Metro Corp. says the changing health care landscape and the challenges of covering rural communities are forcing it to end its area ambulance services. It’s also closing a billing operations center in Indianapolis.
Lilly wins tentative approval for diabetes drug
Final approval could be delayed until mid-2016 due to a claim of patent infringement by drugmaker Sanofi.
Cardinal Health unit seeks tax breaks for local drug facility
A subsidiary of Dublin, Ohio-based Cardinal Health Inc. is seeking tax breaks from the city of Indianapolis to help it open a $14.4 million local drug-production facility that would employ 85 workers by 2017.